Zdrowie i gospodarka · 08/03/2000

FDA to Reclassify Microbiology Devices from Class III to Class II for Public Comment

The FDA is seeking public comment on its recommendation to reclassify fully automated short-term incubation cycle antimicrobial susceptibility devices from Class III to Class II, following a petition from bioMeAE1rieux Vitek, Inc. and a review of publicly available information.